Pharmaceutical Excipients Market By Origin (Organic Chemicals, Inorganic Chemicals, Others); By Functionality (Fillers & Diluents, Binders, Suspension & Viscosity Agents, Coatings, Flavoring Agents, Disintegrants, Colorants, Lubricants & Glidants, Preservatives, Sweeteners, Others); By Formulation (Oral (Solid Dosage, Liquid Dosage), Topical, Parenteral, Others); By Distribution Channel (Direct, Indirect); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia(Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia) Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
The global pharmaceutical excipient market is projected to be driven by the rising demand for medicines and biopharmaceuticals products. The increasing geriatric population across the globe and rising prevalence of chronic diseases has raised the demand for medicines. According to World Health Organization (WHO), around 422 million people suffer from diabetes worldwide, thereby increasing the need for the formulation of various medicines. Excipients are widely used in the formulation to achieve better functionalities such as longer shelf-life, and also render competitive advantage. The increasing cases of oncological disease, neurological diseases and other rare diseases such as gabry disease, gaucher disease have raised the adoption of orphan drugs. This has created a demand for multi-functional excipients as they play an important role in the development of intelligent drug delivery systems, thereby leading to the improvement of the achieved therapeutic effect. These factors have been instrumental in contributing towards the growth of global pharmaceutical excipient market.
The increasing focus on pharmaceutical manufacturing in emerging countries showcases substantial growth opportunities for global pharmaceutical excipient market over the forecast period. Several major pharmaceutical excipient manufacturers are either planning capacity expansions of their existing plants in emerging countries or setting up new manufacturing plants in emerging markets such as China and India, so as to cater to the burgeoning demand and expand their consumer base.
The outbreak of COVID 19 led to a surge in demand for the drugs such as Remdesivir and hydroxychloroquine, which significantly accelerated the global pharmaceutical excipient market due to increased process of drug development and manufacturing of raw materials. Also, the key players in the market are focusing on adopting strategies to strengthen the market, which is further impelling the market growth. For instance, in 2020, Evonik launched RESOMER Precise platform of custom functional excipients to precisely control the release profile of parenteral drug products.
In terms of revenue, global pharmaceutical excipient market was valued at US$ 7,322.44 Mn in 2021 growing at a CAGR of 5.7% over the forecast period (2022 – 2030). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Pharmaceutical Excipeint Market Revenue & Forecast, (US$ Million), 2015 – 2030
Origin Outlook:
Based on origin, the global pharmaceutical excipient market is segmented into organic chemicals, inorganic chemicals and others. As of 2021, the organic chemical segment dominated the market due to its increased use in varied pharmaceuticals formulations. Organic chemical is widely used across conventional dosage forms as well as in novel drug delivery systems, which is thereby boosting the segment’s growth in the global market.
Functionality Outlook:
Based on functionality, the pharmaceutical excipient market is segmented into Fillers & diluents, binders, suspension & viscosity agents, coatings, flavoring agents, disintegrants, colorants, lubricants & glidants, preservatives, sweeteners, others. The fillers and diluents segment accounted for the highest share in the global market as they are widely used in manufacturing of tablets and capsules to increase the bulk weight of tablet or solid dosage form.
Formulation Outlook
Based on formulation, the pharmaceutical excipient market is segmented into oral, topical, parenteral and others. The oral segment held the highest share in 2021 due its wide usage and efficacy against several ailments. Many pharmaceutical companies are increasingly partnering with oral excipient specialists who can enable, enhance and differentiate their oral solid dosage forms, thereby impelling the market growth.
Distribution Channel Outlook
Based on distribution channel, the pharmaceutical excipient market is segmented into direct and indirect. The direct distribution channel dominates the market as it is a primary base for the distribution of excipients. End users are directly approaching pharmaceutical excipient manufacturers for their customised solutions, which is contributing towards the segment’s growth in the global market.
Regional Outlook
North America dominated the global pharmaceutical excipient market in 2021. The increasing demand for orphan drugs in the region is a major factor contributing to the market growth. Moreover, the increasing research & development in the sector along with increased focus of key players on the launch of new products and other strategic initiatives is fuelling the market growth. For instance, In April 2019, Colorcon, Inc. (U.S.) signed an agreement with DuPont Nutrition and Biosciences (U.S.) in order to enhance the current product portfolio of CR Alliance products. Moreover, in U.S, demand for pharmaceuticals has fuelled the growth of drug production, and consequently, excipient consumption.
Competitive Landscape
The report provides both, qualitative and quantitative research of the global pharmaceutical excipient market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyses in the report. For each company, the report studies their global presence, competitors, service offerings, and specification amongst others.
Some of the key players operating in the global pharmaceutical excipient market are:
- ADM
- Armor Pharma
- Asahi Kasei India Pvt. Ltd.
- BASF Corporation
- BENEO
- Biogrund GmbH
- Chemische Fabrik Budenheim KG
- Daicel Corporation
- Evonik Industries AG
- Kerry
- Other Market Participants
Global Pharmaceutical Excipient Market
- By Origin
- Organic Chemical
- Inorganic Chemical
- Others
- By Functionality
- Fillers & Diluents
- Binders
- Suspension & Viscosity Agents
- Coatings
- Flavoring Agents
- Disintegrants
- Colorants
- Lubricants & Glidants
- Preservatives
- Sweeteners
- Others
- By Formulation
- Oral
- Solid Dosage
- Liquid Dosage
- Topical
- Parenteral
- Others
- By Distribution Channel
- Direct
- Indirect
By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2020
1.2.2. Base
Year: 2021
1.2.3. Forecast
Years: 2022 – 2030
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Pharmaceutical Excipient Market
6. Market Synopsis:
Pharmaceutical Excipient Market
7. Pharmaceutical Excipient Market Analysis: Qualitative
Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Pharmaceutical Excipient Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Pharmaceutical Excipient Market
7.6. Porter’s
Five Force Analysis
7.7. Impact of
Covid-19 on Pharmaceutical Excipient Market
8. Global Pharmaceutical Excipient Market Analysis and
Forecasts, 2022 – 2030
8.1. Overview
8.1.1. Global
Pharmaceutical Excipient Market Revenue (US$ Mn)
8.2. Global
Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts, By Origin
8.2.1. Organic
Chemical
8.2.1.1. Definition
8.2.1.2. Market Estimation and Penetration, 2015 - 2021
8.2.1.3. Market Forecast, 2022 - 2030
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. North
America
8.2.1.5.1.1. Market
Estimation, 2015 - 2021
8.2.1.5.1.2. Market
Forecast, 2022 - 2030
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 - 2021
8.2.1.5.2.2. Market
Forecast, 2022 - 2030
8.2.1.5.3. Asia
Pacific
8.2.1.5.3.1. Market
Estimation, 2015 - 2021
8.2.1.5.3.2. Market
Forecast, 2022 - 2030
8.2.1.5.4. Middle
East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 - 2021
8.2.1.5.4.2. Market
Forecast, 2022 - 2030
8.2.1.5.5. Latin
America
8.2.1.5.5.1. Market
Estimation, 2015 - 2021
8.2.1.5.5.2. Market
Forecast, 2022 - 2030
8.2.2. Inorganic
Chemical
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 - 2021
8.2.2.3. Market Forecast, 2022 - 2030
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North
America
8.2.2.5.1.1. Market
Estimation, 2015 - 2021
8.2.2.5.1.2. Market
Forecast, 2022 - 2030
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2021
8.2.2.5.2.2. Market
Forecast, 2022 - 2030
8.2.2.5.3. Asia
Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2021
8.2.2.5.3.2. Market
Forecast, 2022 - 2030
8.2.2.5.4. Middle
East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2021
8.2.2.5.4.2. Market
Forecast, 2022 - 2030
8.2.2.5.5. Latin
America
8.2.2.5.5.1. Market
Estimation, 2015 - 2021
8.2.2.5.5.2. Market
Forecast, 2022 - 2030
8.2.3. Others
8.2.3.1. Definition
8.2.3.2. Market Estimation and Penetration, 2015 - 2021
8.2.3.3. Market Forecast, 2022 - 2030
8.2.3.4. Compound Annual Growth Rate (CAGR)
8.2.3.5. Regional Bifurcation
8.2.3.5.1. North
America
8.2.3.5.1.1. Market
Estimation, 2015 - 2021
8.2.3.5.1.2. Market
Forecast, 2022 - 2030
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 - 2021
8.2.3.5.2.2. Market
Forecast, 2022 - 2030
8.2.3.5.3. Asia
Pacific
8.2.3.5.3.1. Market
Estimation, 2015 - 2021
8.2.3.5.3.2. Market
Forecast, 2022 - 2030
8.2.3.5.4. Middle
East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 - 2021
8.2.3.5.4.2. Market
Forecast, 2022 - 2030
8.2.3.5.5. Latin
America
8.2.3.5.5.1. Market
Estimation, 2015 - 2021
8.2.3.5.5.2. Market
Forecast, 2022 - 2030
8.3. Key
Segment for Channeling Investments
8.3.1. By
Origin
9. Global Pharmaceutical Excipient Market Analysis and
Forecasts, 2022 – 2030
9.1. Overview
9.2. Global
Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts, By Functionality
9.2.1. Fillers
and Diluents
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 - 2021
9.2.1.3. Market Forecast, 2022 - 2030
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North
America
9.2.1.5.1.1. Market
Estimation, 2015 - 2021
9.2.1.5.1.2. Market
Forecast, 2022 - 2030
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2021
9.2.1.5.2.2. Market
Forecast, 2022 - 2030
9.2.1.5.3. Asia
Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2021
9.2.1.5.3.2. Market
Forecast, 2022 - 2030
9.2.1.5.4. Middle
East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2021
9.2.1.5.4.2. Market
Forecast, 2022 - 2030
9.2.1.5.5. Latin
America
9.2.1.5.5.1. Market
Estimation, 2015 - 2021
9.2.1.5.5.2. Market
Forecast, 2022 - 2030
9.2.2. Binders
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 - 2021
9.2.2.3. Market Forecast, 2022 - 2030
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North
America
9.2.2.5.1.1. Market
Estimation, 2015 - 2021
9.2.2.5.1.2. Market
Forecast, 2022 - 2030
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2021
9.2.2.5.2.2. Market
Forecast, 2022 - 2030
9.2.2.5.3. Asia
Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2021
9.2.2.5.3.2. Market
Forecast, 2022 - 2030
9.2.2.5.4. Middle
East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2021
9.2.2.5.4.2. Market
Forecast, 2022 - 2030
9.2.2.5.5. Latin
America
9.2.2.5.5.1. Market
Estimation, 2015 - 2021
9.2.2.5.5.2. Market
Forecast, 2022 - 2030
9.2.3. Suspension
and Viscosity Agents
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 - 2021
9.2.3.3. Market Forecast, 2022 - 2030
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North
America
9.2.3.5.1.1. Market
Estimation, 2015 - 2021
9.2.3.5.1.2. Market
Forecast, 2022 - 2030
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 - 2021
9.2.3.5.2.2. Market
Forecast, 2022 - 2030
9.2.3.5.3. Asia
Pacific
9.2.3.5.3.1. Market
Estimation, 2015 - 2021
9.2.3.5.3.2. Market
Forecast, 2022 - 2030
9.2.3.5.4. Middle
East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 - 2021
9.2.3.5.4.2. Market
Forecast, 2022 - 2030
9.2.3.5.5. Latin
America
9.2.3.5.5.1. Market
Estimation, 2015 - 2021
9.2.3.5.5.2. Market
Forecast, 2022 - 2030
9.2.4. Coatings
9.2.4.1. Definition
9.2.4.2. Market Estimation and Penetration, 2015 - 2021
9.2.4.3. Market Forecast, 2022 - 2030
9.2.4.4. Compound Annual Growth Rate (CAGR)
9.2.4.5. Regional Bifurcation
9.2.4.5.1. North
America
9.2.4.5.1.1. Market
Estimation, 2015 - 2021
9.2.4.5.1.2. Market
Forecast, 2022 - 2030
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 - 2021
9.2.4.5.2.2. Market
Forecast, 2022 - 2030
9.2.4.5.3. Asia
Pacific
9.2.4.5.3.1. Market
Estimation, 2015 - 2021
9.2.4.5.3.2. Market
Forecast, 2022 - 2030
9.2.4.5.4. Middle
East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 - 2021
9.2.4.5.4.2. Market
Forecast, 2022 - 2030
9.2.4.5.5. Latin
America
9.2.4.5.5.1. Market
Estimation, 2015 - 2021
9.2.4.5.5.2. Market
Forecast, 2022 - 2030
9.2.5. Flavoring
Agents
9.2.5.1. Definition
9.2.5.2. Market Estimation and Penetration, 2015 - 2021
9.2.5.3. Market Forecast, 2022 - 2030
9.2.5.4. Compound Annual Growth Rate (CAGR)
9.2.5.5. Regional Bifurcation
9.2.5.5.1. North
America
9.2.5.5.1.1. Market
Estimation, 2015 - 2021
9.2.5.5.1.2. Market
Forecast, 2022 - 2030
9.2.5.5.2. Europe
9.2.5.5.2.1. Market
Estimation, 2015 - 2021
9.2.5.5.2.2. Market
Forecast, 2022 - 2030
9.2.5.5.3. Asia
Pacific
9.2.5.5.3.1. Market
Estimation, 2015 - 2021
9.2.5.5.3.2. Market
Forecast, 2022 - 2030
9.2.5.5.4. Middle
East and Africa
9.2.5.5.4.1. Market
Estimation, 2015 - 2021
9.2.5.5.4.2. Market
Forecast, 2022 - 2030
9.2.5.5.5. Latin
America
9.2.5.5.5.1. Market
Estimation, 2015 - 2021
9.2.5.5.5.2. Market
Forecast, 2022 - 2030
9.2.6. Disintegrants
9.2.6.1. Definition
9.2.6.2. Market Estimation and Penetration, 2015 - 2021
9.2.6.3. Market Forecast, 2022 - 2030
9.2.6.4. Compound Annual Growth Rate (CAGR)
9.2.6.5. Regional Bifurcation
9.2.6.5.1. North
America
9.2.6.5.1.1. Market
Estimation, 2015 - 2021
9.2.6.5.1.2. Market
Forecast, 2022 - 2030
9.2.6.5.2. Europe
9.2.6.5.2.1. Market
Estimation, 2015 - 2021
9.2.6.5.2.2. Market
Forecast, 2022 - 2030
9.2.6.5.3. Asia
Pacific
9.2.6.5.3.1. Market
Estimation, 2015 - 2021
9.2.6.5.3.2. Market
Forecast, 2022 - 2030
9.2.6.5.4. Middle
East and Africa
9.2.6.5.4.1. Market
Estimation, 2015 - 2021
9.2.6.5.4.2. Market
Forecast, 2022 - 2030
9.2.6.5.5. Latin
America
9.2.6.5.5.1. Market
Estimation, 2015 - 2021
9.2.6.5.5.2. Market
Forecast, 2022 - 2030
9.2.7. Colorants
9.2.7.1. Definition
9.2.7.2. Market Estimation and Penetration, 2015 - 2021
9.2.7.3. Market Forecast, 2022 - 2030
9.2.7.4. Compound Annual Growth Rate (CAGR)
9.2.7.5. Regional Bifurcation
9.2.7.5.1. North
America
9.2.7.5.1.1. Market
Estimation, 2015 - 2021
9.2.7.5.1.2. Market
Forecast, 2022 - 2030
9.2.7.5.2. Europe
9.2.7.5.2.1. Market
Estimation, 2015 - 2021
9.2.7.5.2.2. Market
Forecast, 2022 - 2030
9.2.7.5.3. Asia
Pacific
9.2.7.5.3.1. Market
Estimation, 2015 - 2021
9.2.7.5.3.2. Market
Forecast, 2022 - 2030
9.2.7.5.4. Middle
East and Africa
9.2.7.5.4.1. Market
Estimation, 2015 - 2021
9.2.7.5.4.2. Market
Forecast, 2022 - 2030
9.2.7.5.5. Latin
America
9.2.7.5.5.1. Market
Estimation, 2015 - 2021
9.2.7.5.5.2. Market
Forecast, 2022 - 2030
9.2.8. Lubricants
and Glidants
9.2.8.1. Definition
9.2.8.2. Market Estimation and Penetration, 2015 - 2021
9.2.8.3. Market Forecast, 2022 - 2030
9.2.8.4. Compound Annual Growth Rate (CAGR)
9.2.8.5. Regional Bifurcation
9.2.8.5.1. North
America
9.2.8.5.1.1. Market
Estimation, 2015 - 2021
9.2.8.5.1.2. Market
Forecast, 2022 - 2030
9.2.8.5.2. Europe
9.2.8.5.2.1. Market
Estimation, 2015 - 2021
9.2.8.5.2.2. Market
Forecast, 2022 - 2030
9.2.8.5.3. Asia
Pacific
9.2.8.5.3.1. Market
Estimation, 2015 - 2021
9.2.8.5.3.2. Market
Forecast, 2022 - 2030
9.2.8.5.4. Middle
East and Africa
9.2.8.5.4.1. Market
Estimation, 2015 - 2021
9.2.8.5.4.2. Market
Forecast, 2022 - 2030
9.2.8.5.5. Latin
America
9.2.8.5.5.1. Market
Estimation, 2015 - 2021
9.2.8.5.5.2. Market
Forecast, 2022 - 2030
9.2.9. Preservatives
9.2.9.1. Definition
9.2.9.2. Market Estimation and Penetration, 2015 - 2021
9.2.9.3. Market Forecast, 2022 - 2030
9.2.9.4. Compound Annual Growth Rate (CAGR)
9.2.9.5. Regional Bifurcation
9.2.9.5.1. North
America
9.2.9.5.1.1. Market
Estimation, 2015 - 2021
9.2.9.5.1.2. Market
Forecast, 2022 - 2030
9.2.9.5.2. Europe
9.2.9.5.2.1. Market
Estimation, 2015 - 2021
9.2.9.5.2.2. Market
Forecast, 2022 - 2030
9.2.9.5.3. Asia
Pacific
9.2.9.5.3.1. Market
Estimation, 2015 - 2021
9.2.9.5.3.2. Market
Forecast, 2022 - 2030
9.2.9.5.4. Middle
East and Africa
9.2.9.5.4.1. Market
Estimation, 2015 - 2021
9.2.9.5.4.2. Market
Forecast, 2022 - 2030
9.2.9.5.5. Latin
America
9.2.9.5.5.1. Market
Estimation, 2015 - 2021
9.2.9.5.5.2. Market
Forecast, 2022 - 2030
9.2.10. Sweeteners
9.2.10.1. Definition
9.2.10.2. Market Estimation and Penetration, 2015 - 2021
9.2.10.3. Market Forecast, 2022 - 2030
9.2.10.4. Compound Annual Growth Rate (CAGR)
9.2.10.5. Regional Bifurcation
9.2.10.5.1. North
America
9.2.10.5.1.1. Market
Estimation, 2015 - 2021
9.2.10.5.1.2. Market
Forecast, 2022 - 2030
9.2.10.5.2. Europe
9.2.10.5.2.1. Market
Estimation, 2015 - 2021
9.2.10.5.2.2. Market
Forecast, 2022 - 2030
9.2.10.5.3. Asia
Pacific
9.2.10.5.3.1. Market
Estimation, 2015 - 2021
9.2.10.5.3.2. Market
Forecast, 2022 - 2030
9.2.10.5.4. Middle
East and Africa
9.2.10.5.4.1. Market
Estimation, 2015 - 2021
9.2.10.5.4.2. Market
Forecast, 2022 - 2030
9.2.10.5.5. Latin
America
9.2.10.5.5.1. Market
Estimation, 2015 - 2021
9.2.10.5.5.2. Market
Forecast, 2022 - 2030
9.2.11. Others
9.2.11.1. Definition
9.2.11.2. Market Estimation and Penetration, 2015 - 2021
9.2.11.3. Market Forecast, 2022 - 2030
9.2.11.4. Compound Annual Growth Rate (CAGR)
9.2.11.5. Regional Bifurcation
9.2.11.5.1. North
America
9.2.11.5.1.1. Market
Estimation, 2015 - 2021
9.2.11.5.1.2. Market
Forecast, 2022 - 2030
9.2.11.5.2. Europe
9.2.11.5.2.1. Market
Estimation, 2015 - 2021
9.2.11.5.2.2. Market
Forecast, 2022 - 2030
9.2.11.5.3. Asia
Pacific
9.2.11.5.3.1. Market
Estimation, 2015 - 2021
9.2.11.5.3.2. Market
Forecast, 2022 - 2030
9.2.11.5.4. Middle
East and Africa
9.2.11.5.4.1. Market
Estimation, 2015 - 2021
9.2.11.5.4.2. Market
Forecast, 2022 - 2030
9.2.11.5.5. Latin
America
9.2.11.5.5.1. Market
Estimation, 2015 - 2021
9.2.11.5.5.2. Market
Forecast, 2022 - 2030
9.3. Key
Segment for Channeling Investments
9.3.1. By Functionality
10. Global Pharmaceutical Excipient Market Analysis and Forecasts,
2022 – 2030
10.1. Overview
10.2. Global
Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts, By Formulation
10.2.1. Oral
(Definition, Market Estimation and Penetration, 2015 - 2021, Market Estimation
(2015 - 2021), Market Forecast (2022 - 2030), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Solid Dosage, Liquid Dosage)
10.2.1.1. Solid Dosage
10.2.1.2. Liquid Dosage
10.2.2. Topical
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 - 2021
10.2.2.3. Market Forecast, 2022 - 2030
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North
America
10.2.2.5.1.1. Market
Estimation, 2015 - 2021
10.2.2.5.1.2. Market
Forecast, 2022 - 2030
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2021
10.2.2.5.2.2. Market
Forecast, 2022 - 2030
10.2.2.5.3. Asia
Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2021
10.2.2.5.3.2. Market
Forecast, 2022 - 2030
10.2.2.5.4. Middle
East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2021
10.2.2.5.4.2. Market
Forecast, 2022 - 2030
10.2.2.5.5. Latin
America
10.2.2.5.5.1. Market
Estimation, 2015 - 2021
10.2.2.5.5.2. Market
Forecast, 2022 - 2030
10.2.3. Parenteral
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 - 2021
10.2.3.3. Market Forecast, 2022 - 2030
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North
America
10.2.3.5.1.1. Market
Estimation, 2015 - 2021
10.2.3.5.1.2. Market
Forecast, 2022 - 2030
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 - 2021
10.2.3.5.2.2. Market
Forecast, 2022 - 2030
10.2.3.5.3. Asia
Pacific
10.2.3.5.3.1. Market
Estimation, 2015 - 2021
10.2.3.5.3.2. Market
Forecast, 2022 - 2030
10.2.3.5.4. Middle
East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 - 2021
10.2.3.5.4.2. Market
Forecast, 2022 - 2030
10.2.3.5.5. Latin
America
10.2.3.5.5.1. Market
Estimation, 2015 - 2021
10.2.3.5.5.2. Market
Forecast, 2022 - 2030
10.2.4. Others
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2015 - 2021
10.2.4.3. Market Forecast, 2022 - 2030
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North
America
10.2.4.5.1.1. Market
Estimation, 2015 - 2021
10.2.4.5.1.2. Market
Forecast, 2022 - 2030
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation, 2015 - 2021
10.2.4.5.2.2. Market
Forecast, 2022 - 2030
10.2.4.5.3. Asia
Pacific
10.2.4.5.3.1. Market
Estimation, 2015 - 2021
10.2.4.5.3.2. Market
Forecast, 2022 - 2030
10.2.4.5.4. Middle
East and Africa
10.2.4.5.4.1. Market
Estimation, 2015 - 2021
10.2.4.5.4.2. Market
Forecast, 2022 - 2030
10.2.4.5.5. Latin
America
10.2.4.5.5.1. Market
Estimation, 2015 - 2021
10.2.4.5.5.2. Market
Forecast, 2022 - 2030
10.3. Key
Segment for Channeling Investments
10.3.1. By
Formulation
11. Global Pharmaceutical Excipient Market Analysis and
Forecasts, 2022 – 2030
11.1. Overview
11.2. Global
Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
11.2.1. Direct
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 - 2021
11.2.1.3. Market Forecast, 2022 - 2030
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North
America
11.2.1.5.1.1. Market
Estimation, 2015 - 2021
11.2.1.5.1.2. Market
Forecast, 2022 - 2030
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 - 2021
11.2.1.5.2.2. Market
Forecast, 2022 - 2030
11.2.1.5.3. Asia
Pacific
11.2.1.5.3.1. Market
Estimation, 2015 - 2021
11.2.1.5.3.2. Market
Forecast, 2022 - 2030
11.2.1.5.4. Middle
East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 - 2021
11.2.1.5.4.2. Market
Forecast, 2022 - 2030
11.2.1.5.5. Latin
America
11.2.1.5.5.1. Market
Estimation, 2015 - 2021
11.2.1.5.5.2. Market
Forecast, 2022 - 2030
11.2.2. Indirect
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 - 2021
11.2.2.3. Market Forecast, 2022 - 2030
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North
America
11.2.2.5.1.1. Market
Estimation, 2015 - 2021
11.2.2.5.1.2. Market
Forecast, 2022 - 2030
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 - 2021
11.2.2.5.2.2. Market
Forecast, 2022 - 2030
11.2.2.5.3. Asia
Pacific
11.2.2.5.3.1. Market
Estimation, 2015 - 2021
11.2.2.5.3.2. Market
Forecast, 2022 - 2030
11.2.2.5.4. Middle
East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 - 2021
11.2.2.5.4.2. Market
Forecast, 2022 - 2030
11.2.2.5.5. Latin
America
11.2.2.5.5.1. Market
Estimation, 2015 - 2021
11.2.2.5.5.2. Market
Forecast, 2022 - 2030
11.3. Key
Segment for Channeling Investments
11.3.1. By
Distribution Channel
12. North America Pharmaceutical Excipient Market Analysis and
Forecasts, 2022 - 2030
12.1. Overview
12.1.1. North
America Pharmaceutical Excipient Market Revenue (US$ Mn)
12.2. North
America Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts, By
Origin
12.2.1. Organic
Chemical
12.2.2. Inorganic
Chemical
12.2.3. Others
12.3. North
America Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts, By Functionality
12.3.1. Fillers
and Diluents
12.3.2. Binders
12.3.3. Suspension
and Viscosity Agents
12.3.4. Coatings
12.3.5. Flavoring
Agents
12.3.6. Disintegrants
12.3.7. Colorants
12.3.8. Lubricants
and Glidants
12.3.9. Preservatives
12.3.10. Sweeteners
12.3.11. Others
12.4. North
America Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts, By
Formulation
12.4.1. Oral
12.4.1.1. Solid Dosage
12.4.1.2. Liquid Dosage
12.4.2. Topical
12.4.3. Parenteral
12.4.4. Others
12.5. North
America Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
12.5.1. Direct
12.5.2. Indirect
12.6. North
America Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts, By
Country
12.6.1. U.S
12.6.1.1. U.S Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Origin
12.6.1.1.1. Organic
Chemical
12.6.1.1.2. Inorganic
Chemical
12.6.1.1.3. Others
12.6.1.2. U.S Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Functionality
12.6.1.2.1. Fillers
and Diluents
12.6.1.2.2. Binders
12.6.1.2.3. Suspension
and Viscosity Agents
12.6.1.2.4. Coatings
12.6.1.2.5. Flavoring
Agents
12.6.1.2.6. Disintegrants
12.6.1.2.7. Colorants
12.6.1.2.8. Lubricants
and Glidants
12.6.1.2.9. Preservatives
12.6.1.2.10. Sweeteners
12.6.1.2.11. Others
12.6.1.3. U.S Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Formulation
12.6.1.3.1. Oral
12.6.1.3.1.1. Solid
Dosage
12.6.1.3.1.2. Liquid
Dosage
12.6.1.3.2. Topical
12.6.1.3.3. Parenteral
12.6.1.3.4. Others
12.6.1.4. U.S Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
12.6.1.4.1. Direct
12.6.1.4.2. Indirect
12.6.2. Canada
12.6.2.1. Canada Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Origin
12.6.2.1.1. Organic
Chemical
12.6.2.1.2. Inorganic
Chemical
12.6.2.1.3. Others
12.6.2.2. Canada Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Functionality
12.6.2.2.1. Fillers
and Diluents
12.6.2.2.2. Binders
12.6.2.2.3. Suspension
and Viscosity Agents
12.6.2.2.4. Coatings
12.6.2.2.5. Flavoring
Agents
12.6.2.2.6. Disintegrants
12.6.2.2.7. Colorants
12.6.2.2.8. Lubricants
and Glidants
12.6.2.2.9. Preservatives
12.6.2.2.10. Sweeteners
12.6.2.2.11. Others
12.6.2.3. Canada Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Formulation
12.6.2.3.1. Oral
12.6.2.3.1.1. Solid
Dosage
12.6.2.3.1.2. Liquid
Dosage
12.6.2.3.2. Topical
12.6.2.3.3. Parenteral
12.6.2.3.4. Others
12.6.2.4. Canada Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
12.6.2.4.1. Direct
12.6.2.4.2. Indirect
12.6.3. Mexico
12.6.3.1. Mexico Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Origin
12.6.3.1.1. Organic
Chemical
12.6.3.1.2. Inorganic
Chemical
12.6.3.1.3. Others
12.6.3.2. Mexico Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Functionality
12.6.3.2.1. Fillers
and Diluents
12.6.3.2.2. Binders
12.6.3.2.3. Suspension
and Viscosity Agents
12.6.3.2.4. Coatings
12.6.3.2.5. Flavoring
Agents
12.6.3.2.6. Disintegrants
12.6.3.2.7. Colorants
12.6.3.2.8. Lubricants
and Glidants
12.6.3.2.9. Preservatives
12.6.3.2.10. Sweeteners
12.6.3.2.11. Others
12.6.3.3. Mexico Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Formulation
12.6.3.3.1. Oral
12.6.3.3.1.1. Solid
Dosage
12.6.3.3.1.2. Liquid
Dosage
12.6.3.3.2. Topical
12.6.3.3.3. Parenteral
12.6.3.3.4. Others
12.6.3.4. Mexico Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
12.6.3.4.1. Direct
12.6.3.4.2. Indirect
12.6.4. Rest of
North America
12.6.4.1. Rest of North America Pharmaceutical Excipient Market Revenue
(US$ Mn) and Forecasts, By Origin
12.6.4.1.1. Organic
Chemical
12.6.4.1.2. Inorganic
Chemical
12.6.4.1.3. Others
12.6.4.2. Rest of North America Pharmaceutical Excipient Market Revenue
(US$ Mn) and Forecasts, By Functionality
12.6.4.2.1. Fillers
and Diluents
12.6.4.2.2. Binders
12.6.4.2.3. Suspension
and Viscosity Agents
12.6.4.2.4. Coatings
12.6.4.2.5. Flavoring
Agents
12.6.4.2.6. Disintegrants
12.6.4.2.7. Colorants
12.6.4.2.8. Lubricants
and Glidants
12.6.4.2.9. Preservatives
12.6.4.2.10. Sweeteners
12.6.4.2.11. Others
12.6.4.3. Rest of North America Pharmaceutical Excipient Market Revenue
(US$ Mn) and Forecasts, By Formulation
12.6.4.3.1. Oral
12.6.4.3.1.1. Solid
Dosage
12.6.4.3.1.2. Liquid
Dosage
12.6.4.3.2. Topical
12.6.4.3.3. Parenteral
12.6.4.3.4. Others
12.6.4.4. Rest of North America Pharmaceutical Excipient Market Revenue
(US$ Mn) and Forecasts, By Distribution Channel
12.6.4.4.1. Direct
12.6.4.4.2. Indirect
12.7. Key
Segment for Channeling Investments
12.7.1. By
Country
12.7.2. By
Origin
12.7.3. By Functionality
12.7.4. By
Formulation
12.7.5. By
Distribution Channel
13. Europe Pharmaceutical Excipient Market Analysis and
Forecasts, 2022 - 2030
13.1. Overview
13.1.1. Europe
Pharmaceutical Excipient Market Revenue (US$ Mn)
13.2. Europe
Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts, By Origin
13.2.1. Organic
Chemical
13.2.2. Inorganic
Chemical
13.2.3. Others
13.3. Europe
Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts, By Functionality
13.3.1. Fillers
and Diluents
13.3.2. Binders
13.3.3. Suspension
and Viscosity Agents
13.3.4. Coatings
13.3.5. Flavoring
Agents
13.3.6. Disintegrants
13.3.7. Colorants
13.3.8. Lubricants
and Glidants
13.3.9. Preservatives
13.3.10. Sweeteners
13.3.11. Others
13.4. Europe
Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts, By Formulation
13.4.1. Oral
13.4.1.1. Solid Dosage
13.4.1.2. Liquid Dosage
13.4.2. Topical
13.4.3. Parenteral
13.4.4. Others
13.5. Europe
Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
13.5.1. Direct
13.5.2. Indirect
13.6. Europe
Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts, By Country
13.6.1. France
13.6.1.1. France Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Origin
13.6.1.1.1. Organic
Chemical
13.6.1.1.2. Inorganic
Chemical
13.6.1.1.3. Others
13.6.1.2. France Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Functionality
13.6.1.2.1. Fillers
and Diluents
13.6.1.2.2. Binders
13.6.1.2.3. Suspension
and Viscosity Agents
13.6.1.2.4. Coatings
13.6.1.2.5. Flavoring
Agents
13.6.1.2.6. Disintegrants
13.6.1.2.7. Colorants
13.6.1.2.8. Lubricants
and Glidants
13.6.1.2.9. Preservatives
13.6.1.2.10. Sweeteners
13.6.1.2.11. Others
13.6.1.3. France Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Formulation
13.6.1.3.1. Oral
13.6.1.3.1.1. Solid
Dosage
13.6.1.3.1.2. Liquid
Dosage
13.6.1.3.2. Topical
13.6.1.3.3. Parenteral
13.6.1.3.4. Others
13.6.1.4. France Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
13.6.1.4.1. Direct
13.6.1.4.2. Indirect
13.6.2. The UK
13.6.2.1. The UK Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Origin
13.6.2.1.1. Organic
Chemical
13.6.2.1.2. Inorganic
Chemical
13.6.2.1.3. Others
13.6.2.2. The UK Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Functionality
13.6.2.2.1. Fillers
and Diluents
13.6.2.2.2. Binders
13.6.2.2.3. Suspension
and Viscosity Agents
13.6.2.2.4. Coatings
13.6.2.2.5. Flavoring
Agents
13.6.2.2.6. Disintegrants
13.6.2.2.7. Colorants
13.6.2.2.8. Lubricants
and Glidants
13.6.2.2.9. Preservatives
13.6.2.2.10. Sweeteners
13.6.2.2.11. Others
13.6.2.3. The UK Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Formulation
13.6.2.3.1. Oral
13.6.2.3.1.1. Solid
Dosage
13.6.2.3.1.2. Liquid
Dosage
13.6.2.3.2. Topical
13.6.2.3.3. Parenteral
13.6.2.3.4. Others
13.6.2.4. The UK Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
13.6.2.4.1. Direct
13.6.2.4.2. Indirect
13.6.3. Spain
13.6.3.1. Spain Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Origin
13.6.3.1.1. Organic
Chemical
13.6.3.1.2. Inorganic
Chemical
13.6.3.1.3. Others
13.6.3.2. Spain Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Functionality
13.6.3.2.1. Fillers
and Diluents
13.6.3.2.2. Binders
13.6.3.2.3. Suspension
and Viscosity Agents
13.6.3.2.4. Coatings
13.6.3.2.5. Flavoring
Agents
13.6.3.2.6. Disintegrants
13.6.3.2.7. Colorants
13.6.3.2.8. Lubricants
and Glidants
13.6.3.2.9. Preservatives
13.6.3.2.10. Sweeteners
13.6.3.2.11. Others
13.6.3.3. Spain Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Formulation
13.6.3.3.1. Oral
13.6.3.3.1.1. Solid
Dosage
13.6.3.3.1.2. Liquid
Dosage
13.6.3.3.2. Topical
13.6.3.3.3. Parenteral
13.6.3.3.4. Others
13.6.3.4. Spain Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
13.6.3.4.1. Direct
13.6.3.4.2. Indirect
13.6.4. Germany
13.6.4.1. Germany Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts,
By Origin
13.6.4.1.1. Organic
Chemical
13.6.4.1.2. Inorganic
Chemical
13.6.4.1.3. Others
13.6.4.2. Germany Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Functionality
13.6.4.2.1. Fillers
and Diluents
13.6.4.2.2. Binders
13.6.4.2.3. Suspension
and Viscosity Agents
13.6.4.2.4. Coatings
13.6.4.2.5. Flavoring
Agents
13.6.4.2.6. Disintegrants
13.6.4.2.7. Colorants
13.6.4.2.8. Lubricants
and Glidants
13.6.4.2.9. Preservatives
13.6.4.2.10. Sweeteners
13.6.4.2.11. Others
13.6.4.3. Germany Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Formulation
13.6.4.3.1. Oral
13.6.4.3.1.1. Solid
Dosage
13.6.4.3.1.2. Liquid
Dosage
13.6.4.3.2. Topical
13.6.4.3.3. Parenteral
13.6.4.3.4. Others
13.6.4.4. Germany Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
13.6.4.4.1. Direct
13.6.4.4.2. Indirect
13.6.5. Italy
13.6.5.1. Italy Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Origin
13.6.5.1.1. Organic
Chemical
13.6.5.1.2. Inorganic
Chemical
13.6.5.1.3. Others
13.6.5.2. Italy Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts,
By Functionality
13.6.5.2.1. Fillers
and Diluents
13.6.5.2.2. Binders
13.6.5.2.3. Suspension
and Viscosity Agents
13.6.5.2.4. Coatings
13.6.5.2.5. Flavoring
Agents
13.6.5.2.6. Disintegrants
13.6.5.2.7. Colorants
13.6.5.2.8. Lubricants
and Glidants
13.6.5.2.9. Preservatives
13.6.5.2.10. Sweeteners
13.6.5.2.11. Others
13.6.5.3. Italy Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts,
By Formulation
13.6.5.3.1. Oral
13.6.5.3.1.1. Solid
Dosage
13.6.5.3.1.2. Liquid
Dosage
13.6.5.3.2. Topical
13.6.5.3.3. Parenteral
13.6.5.3.4. Others
13.6.5.4. Italy Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
13.6.5.4.1. Direct
13.6.5.4.2. Indirect
13.6.6. Nordic
Countries
13.6.6.1. Nordic Countries Pharmaceutical Excipient Market Revenue (US$
Mn) and Forecasts, By Origin
13.6.6.1.1. Organic
Chemical
13.6.6.1.2. Inorganic
Chemical
13.6.6.1.3. Others
13.6.6.2. Nordic Countries Pharmaceutical Excipient Market Revenue (US$
Mn) and Forecasts, By Functionality
13.6.6.2.1. Fillers
and Diluents
13.6.6.2.2. Binders
13.6.6.2.3. Suspension
and Viscosity Agents
13.6.6.2.4. Coatings
13.6.6.2.5. Flavoring
Agents
13.6.6.2.6. Disintegrants
13.6.6.2.7. Colorants
13.6.6.2.8. Lubricants
and Glidants
13.6.6.2.9. Preservatives
13.6.6.2.10. Sweeteners
13.6.6.2.11. Others
13.6.6.3. Nordic Countries Pharmaceutical Excipient Market Revenue (US$
Mn) and Forecasts, By Formulation
13.6.6.3.1. Oral
13.6.6.3.1.1. Solid
Dosage
13.6.6.3.1.2. Liquid
Dosage
13.6.6.3.2. Topical
13.6.6.3.3. Parenteral
13.6.6.3.4. Others
13.6.6.4. Nordic Countries Pharmaceutical Excipient Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
13.6.6.4.1. Direct
13.6.6.4.2. Indirect
13.6.6.5. Nordic Countries Pharmaceutical Excipient Market Revenue (US$
Mn) and Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7. Benelux
Union
13.6.7.1. Benelux Union Pharmaceutical Excipient Market Revenue (US$ Mn)
and Forecasts, By Origin
13.6.7.1.1. Organic
Chemical
13.6.7.1.2. Inorganic
Chemical
13.6.7.1.3. Others
13.6.7.2. Benelux Union Pharmaceutical Excipient Market Revenue (US$ Mn)
and Forecasts, By Functionality
13.6.7.2.1. Fillers
and Diluents
13.6.7.2.2. Binders
13.6.7.2.3. Suspension
and Viscosity Agents
13.6.7.2.4. Coatings
13.6.7.2.5. Flavoring
Agents
13.6.7.2.6. Disintegrants
13.6.7.2.7. Colorants
13.6.7.2.8. Lubricants
and Glidants
13.6.7.2.9. Preservatives
13.6.7.2.10. Sweeteners
13.6.7.2.11. Others
13.6.7.3. Benelux Union Pharmaceutical Excipient Market Revenue (US$ Mn)
and Forecasts, By Formulation
13.6.7.3.1. Oral
13.6.7.3.1.1. Solid
Dosage
13.6.7.3.1.2. Liquid
Dosage
13.6.7.3.2. Topical
13.6.7.3.3. Parenteral
13.6.7.3.4. Others
13.6.7.4. Benelux Union Pharmaceutical Excipient Market Revenue (US$ Mn)
and Forecasts, By Distribution Channel
13.6.7.4.1. Direct
13.6.7.4.2. Indirect
13.6.7.5. Benelux Union Pharmaceutical Excipient Market Revenue (US$ Mn)
and Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2. The
Netherlands
13.6.7.5.3. Luxembourg
13.6.8. Rest of
Europe
13.6.8.1. Rest of Europe Pharmaceutical Excipient Market Revenue (US$
Mn) and Forecasts, By Origin
13.6.8.1.1. Organic
Chemical
13.6.8.1.2. Inorganic
Chemical
13.6.8.1.3. Others
13.6.8.2. Rest of Europe Pharmaceutical Excipient Market Revenue (US$
Mn) and Forecasts, By Functionality
13.6.8.2.1. Fillers
and Diluents
13.6.8.2.2. Binders
13.6.8.2.3. Suspension
and Viscosity Agents
13.6.8.2.4. Coatings
13.6.8.2.5. Flavoring
Agents
13.6.8.2.6. Disintegrants
13.6.8.2.7. Colorants
13.6.8.2.8. Lubricants
and Glidants
13.6.8.2.9. Preservatives
13.6.8.2.10. Sweeteners
13.6.8.2.11. Others
13.6.8.3. Rest of Europe Pharmaceutical Excipient Market Revenue (US$
Mn) and Forecasts, By Formulation
13.6.8.3.1. Oral
13.6.8.3.1.1. Solid
Dosage
13.6.8.3.1.2. Liquid
Dosage
13.6.8.3.2. Topical
13.6.8.3.3. Parenteral
13.6.8.3.4. Others
13.6.8.4. Rest of Europe Pharmaceutical Excipient Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
13.6.8.4.1. Direct
13.6.8.4.2. Indirect
13.7. Key
Segment for Channeling Investments
13.7.1. By
Country
13.7.2. By
Origin
13.7.3. By Functionality
13.7.4. By
Formulation
13.7.5. By
Distribution Channel
14. Asia Pacific Pharmaceutical Excipient Market Analysis and
Forecasts, 2022 - 2030
14.1. Overview
14.1.1. Asia
Pacific Pharmaceutical Excipient Market Revenue (US$ Mn)
14.2. Asia
Pacific Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts, By
Origin
14.2.1. Organic
Chemical
14.2.2. Inorganic
Chemical
14.2.3. Others
14.3. Asia
Pacific Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts, By Functionality
14.3.1. Fillers
and Diluents
14.3.2. Binders
14.3.3. Suspension
and Viscosity Agents
14.3.4. Coatings
14.3.5. Flavoring
Agents
14.3.6. Disintegrants
14.3.7. Colorants
14.3.8. Lubricants
and Glidants
14.3.9. Preservatives
14.3.10. Sweeteners
14.3.11. Others
14.4. Asia
Pacific Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts, By
Formulation
14.4.1. Oral
14.4.1.1. Solid Dosage
14.4.1.2. Liquid Dosage
14.4.2. Topical
14.4.3. Parenteral
14.4.4. Others
14.5. Asia Pacific
Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.5.1. Direct
14.5.2. Indirect
14.6. Asia
Pacific Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts, By
Country
14.6.1. China
14.6.1.1. China Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Origin
14.6.1.1.1. Organic
Chemical
14.6.1.1.2. Inorganic
Chemical
14.6.1.1.3. Others
14.6.1.2. China Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Functionality
14.6.1.2.1. Fillers
and Diluents
14.6.1.2.2. Binders
14.6.1.2.3. Suspension
and Viscosity Agents
14.6.1.2.4. Coatings
14.6.1.2.5. Flavoring
Agents
14.6.1.2.6. Disintegrants
14.6.1.2.7. Colorants
14.6.1.2.8. Lubricants
and Glidants
14.6.1.2.9. Preservatives
14.6.1.2.10. Sweeteners
14.6.1.2.11. Others
14.6.1.3. China Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Formulation
14.6.1.3.1. Oral
14.6.1.3.1.1. Solid
Dosage
14.6.1.3.1.2. Liquid
Dosage
14.6.1.3.2. Topical
14.6.1.3.3. Parenteral
14.6.1.3.4. Others
14.6.1.4. China Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
14.6.1.4.1. Direct
14.6.1.4.2. Indirect
14.6.2. Japan
14.6.2.1. Japan Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Origin
14.6.2.1.1. Organic
Chemical
14.6.2.1.2. Inorganic
Chemical
14.6.2.1.3. Others
14.6.2.2. Japan Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Functionality
14.6.2.2.1. Fillers
and Diluents
14.6.2.2.2. Binders
14.6.2.2.3. Suspension
and Viscosity Agents
14.6.2.2.4. Coatings
14.6.2.2.5. Flavoring
Agents
14.6.2.2.6. Disintegrants
14.6.2.2.7. Colorants
14.6.2.2.8. Lubricants
and Glidants
14.6.2.2.9. Preservatives
14.6.2.2.10. Sweeteners
14.6.2.2.11. Others
14.6.2.3. Japan Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Formulation
14.6.2.3.1. Oral
14.6.2.3.1.1. Solid
Dosage
14.6.2.3.1.2. Liquid
Dosage
14.6.2.3.2. Topical
14.6.2.3.3. Parenteral
14.6.2.3.4. Others
14.6.2.4. Japan Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
14.6.2.4.1. Direct
14.6.2.4.2. Indirect
14.6.3. India
14.6.3.1. India Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Origin
14.6.3.1.1. Organic
Chemical
14.6.3.1.2. Inorganic
Chemical
14.6.3.1.3. Others
14.6.3.2. India Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Functionality
14.6.3.2.1. Fillers
and Diluents
14.6.3.2.2. Binders
14.6.3.2.3. Suspension
and Viscosity Agents
14.6.3.2.4. Coatings
14.6.3.2.5. Flavoring
Agents
14.6.3.2.6. Disintegrants
14.6.3.2.7. Colorants
14.6.3.2.8. Lubricants
and Glidants
14.6.3.2.9. Preservatives
14.6.3.2.10. Sweeteners
14.6.3.2.11. Others
14.6.3.3. India Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Formulation
14.6.3.3.1. Oral
14.6.3.3.1.1. Solid
Dosage
14.6.3.3.1.2. Liquid
Dosage
14.6.3.3.2. Topical
14.6.3.3.3. Parenteral
14.6.3.3.4. Others
14.6.3.4. India Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
14.6.3.4.1. Direct
14.6.3.4.2. Indirect
14.6.4. New
Zealand
14.6.4.1. New Zealand Pharmaceutical Excipient Market Revenue (US$ Mn)
and Forecasts, By Origin
14.6.4.1.1. Organic
Chemical
14.6.4.1.2. Inorganic
Chemical
14.6.4.1.3. Others
14.6.4.2. New Zealand Pharmaceutical Excipient Market Revenue (US$ Mn)
and Forecasts, By Functionality
14.6.4.2.1. Fillers
and Diluents
14.6.4.2.2. Binders
14.6.4.2.3. Suspension
and Viscosity Agents
14.6.4.2.4. Coatings
14.6.4.2.5. Flavoring
Agents
14.6.4.2.6. Disintegrants
14.6.4.2.7. Colorants
14.6.4.2.8. Lubricants
and Glidants
14.6.4.2.9. Preservatives
14.6.4.2.10. Sweeteners
14.6.4.2.11. Others
14.6.4.3. New Zealand Pharmaceutical Excipient Market Revenue (US$ Mn)
and Forecasts, By Formulation
14.6.4.3.1. Oral
14.6.4.3.1.1. Solid
Dosage
14.6.4.3.1.2. Liquid
Dosage
14.6.4.3.2. Topical
14.6.4.3.3. Parenteral
14.6.4.3.4. Others
14.6.4.4. New Zealand Pharmaceutical Excipient Market Revenue (US$ Mn)
and Forecasts, By Distribution Channel
14.6.4.4.1. Direct
14.6.4.4.2. Indirect
14.6.5. Australia
14.6.5.1. Australia Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Origin
14.6.5.1.1. Organic
Chemical
14.6.5.1.2. Inorganic
Chemical
14.6.5.1.3. Others
14.6.5.2. Australia Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Functionality
14.6.5.2.1. Fillers
and Diluents
14.6.5.2.2. Binders
14.6.5.2.3. Suspension
and Viscosity Agents
14.6.5.2.4. Coatings
14.6.5.2.5. Flavoring
Agents
14.6.5.2.6. Disintegrants
14.6.5.2.7. Colorants
14.6.5.2.8. Lubricants
and Glidants
14.6.5.2.9. Preservatives
14.6.5.2.10. Sweeteners
14.6.5.2.11. Others
14.6.5.3. Australia Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Formulation
14.6.5.3.1. Oral
14.6.5.3.1.1. Solid
Dosage
14.6.5.3.1.2. Liquid
Dosage
14.6.5.3.2. Topical
14.6.5.3.3. Parenteral
14.6.5.3.4. Others
14.6.5.4. Australia Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
14.6.5.4.1. Direct
14.6.5.4.2. Indirect
14.6.6. South
Korea
14.6.6.1. South Korea Pharmaceutical Excipient Market Revenue (US$ Mn)
and Forecasts, By Origin
14.6.6.1.1. Organic
Chemical
14.6.6.1.2. Inorganic
Chemical
14.6.6.1.3. Others
14.6.6.2. South Korea Pharmaceutical Excipient Market Revenue (US$ Mn)
and Forecasts, By Functionality
14.6.6.2.1. Fillers
and Diluents
14.6.6.2.2. Binders
14.6.6.2.3. Suspension
and Viscosity Agents
14.6.6.2.4. Coatings
14.6.6.2.5. Flavoring
Agents
14.6.6.2.6. Disintegrants
14.6.6.2.7. Colorants
14.6.6.2.8. Lubricants
and Glidants
14.6.6.2.9. Preservatives
14.6.6.2.10. Sweeteners
14.6.6.2.11. Others
14.6.6.3. South Korea Pharmaceutical Excipient Market Revenue (US$ Mn)
and Forecasts, By Formulation
14.6.6.3.1. Oral
14.6.6.3.1.1. Solid
Dosage
14.6.6.3.1.2. Liquid
Dosage
14.6.6.3.2. Topical
14.6.6.3.3. Parenteral
14.6.6.3.4. Others
14.6.6.4. South Korea Pharmaceutical Excipient Market Revenue (US$ Mn)
and Forecasts, By Distribution Channel
14.6.6.4.1. Direct
14.6.6.4.2. Indirect
14.6.7. Southeast
Asia
14.6.7.1. Southeast Asia Pharmaceutical Excipient Market Revenue (US$
Mn) and Forecasts, By Origin
14.6.7.1.1. Organic
Chemical
14.6.7.1.2. Inorganic
Chemical
14.6.7.1.3. Others
14.6.7.2. Southeast Asia Pharmaceutical Excipient Market Revenue (US$
Mn) and Forecasts, By Functionality
14.6.7.2.1. Fillers
and Diluents
14.6.7.2.2. Binders
14.6.7.2.3. Suspension
and Viscosity Agents
14.6.7.2.4. Coatings
14.6.7.2.5. Flavoring
Agents
14.6.7.2.6. Disintegrants
14.6.7.2.7. Colorants
14.6.7.2.8. Lubricants
and Glidants
14.6.7.2.9. Preservatives
14.6.7.2.10. Sweeteners
14.6.7.2.11. Others
14.6.7.3. Southeast Asia Pharmaceutical Excipient Market Revenue (US$
Mn) and Forecasts, By Formulation
14.6.7.3.1. Oral
14.6.7.3.1.1. Solid
Dosage
14.6.7.3.1.2. Liquid
Dosage
14.6.7.3.2. Topical
14.6.7.3.3. Parenteral
14.6.7.3.4. Others
14.6.7.4. Southeast Asia Pharmaceutical Excipient Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
14.6.7.4.1. Direct
14.6.7.4.2. Indirect
14.6.7.5. Southeast Asia Pharmaceutical Excipient Market Revenue (US$
Mn) and Forecasts, By Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3. Malaysia
14.6.7.5.4. Singapore
14.6.7.5.5. Rest
of Southeast Asia
14.6.8. Rest of
Asia Pacific
14.6.8.1. Rest of Asia Pacific Pharmaceutical Excipient Market Revenue
(US$ Mn) and Forecasts, By Origin
14.6.8.1.1. Organic
Chemical
14.6.8.1.2. Inorganic
Chemical
14.6.8.1.3. Others
14.6.8.2. Rest of Asia Pacific Pharmaceutical Excipient Market Revenue
(US$ Mn) and Forecasts, By Functionality
14.6.8.2.1. Fillers
and Diluents
14.6.8.2.2. Binders
14.6.8.2.3. Suspension
and Viscosity Agents
14.6.8.2.4. Coatings
14.6.8.2.5. Flavoring
Agents
14.6.8.2.6. Disintegrants
14.6.8.2.7. Colorants
14.6.8.2.8. Lubricants
and Glidants
14.6.8.2.9. Preservatives
14.6.8.2.10. Sweeteners
14.6.8.2.11. Others
14.6.8.3. Rest of Asia Pacific Pharmaceutical Excipient Market Revenue
(US$ Mn) and Forecasts, By Formulation
14.6.8.3.1. Oral
14.6.8.3.1.1. Solid
Dosage
14.6.8.3.1.2. Liquid
Dosage
14.6.8.3.2. Topical
14.6.8.3.3. Parenteral
14.6.8.3.4. Others
14.6.8.4. Rest of Asia Pacific Pharmaceutical Excipient Market Revenue
(US$ Mn) and Forecasts, By Distribution Channel
14.6.8.4.1. Direct
14.6.8.4.2. Indirect
14.7. Key
Segment for Channeling Investments
14.7.1. By
Country
14.7.2. By
Origin
14.7.3. By Functionality
14.7.4. By
Formulation
14.7.5. By
Distribution Channel
15. Middle East and Africa Pharmaceutical Excipient Market
Analysis and Forecasts, 2022 - 2030
15.1. Overview
15.1.1. Middle
East and Africa Pharmaceutical Excipient Market Revenue (US$ Mn)
15.2. Middle
East and Africa Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts,
By Origin
15.2.1. Organic
Chemical
15.2.2. Inorganic
Chemical
15.2.3. Others
15.3. Middle
East and Africa Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts,
By Functionality
15.3.1. Fillers
and Diluents
15.3.2. Binders
15.3.3. Suspension
and Viscosity Agents
15.3.4. Coatings
15.3.5. Flavoring
Agents
15.3.6. Disintegrants
15.3.7. Colorants
15.3.8. Lubricants
and Glidants
15.3.9. Preservatives
15.3.10. Sweeteners
15.3.11. Others
15.4. Middle East
and Africa Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts, By
Formulation
15.4.1. Oral
15.4.1.1. Solid Dosage
15.4.1.2. Liquid Dosage
15.4.2. Topical
15.4.3. Parenteral
15.4.4. Others
15.5. Middle
East and Africa Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
15.5.1. Direct
15.5.2. Indirect
15.6. Middle
East and Africa Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts,
By Country
15.6.1. Saudi
Arabia
15.6.1.1. Saudi Arabia Pharmaceutical Excipient Market Revenue (US$ Mn)
and Forecasts, By Origin
15.6.1.1.1. Organic
Chemical
15.6.1.1.2. Inorganic
Chemical
15.6.1.1.3. Others
15.6.1.2. Saudi Arabia Pharmaceutical Excipient Market Revenue (US$ Mn)
and Forecasts, By Functionality
15.6.1.2.1. Fillers
and Diluents
15.6.1.2.2. Binders
15.6.1.2.3. Suspension
and Viscosity Agents
15.6.1.2.4. Coatings
15.6.1.2.5. Flavoring
Agents
15.6.1.2.6. Disintegrants
15.6.1.2.7. Colorants
15.6.1.2.8. Lubricants
and Glidants
15.6.1.2.9. Preservatives
15.6.1.2.10. Sweeteners
15.6.1.2.11. Others
15.6.1.3. Saudi Arabia Pharmaceutical Excipient Market Revenue (US$ Mn)
and Forecasts, By Formulation
15.6.1.3.1. Oral
15.6.1.3.1.1. Solid
Dosage
15.6.1.3.1.2. Liquid
Dosage
15.6.1.3.2. Topical
15.6.1.3.3. Parenteral
15.6.1.3.4. Others
15.6.1.4. Saudi Arabia Pharmaceutical Excipient Market Revenue (US$ Mn)
and Forecasts, By Distribution Channel
15.6.1.4.1. Direct
15.6.1.4.2. Indirect
15.6.2. UAE
15.6.2.1. UAE Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Origin
15.6.2.1.1. Organic
Chemical
15.6.2.1.2. Inorganic
Chemical
15.6.2.1.3. Others
15.6.2.2. UAE Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Functionality
15.6.2.2.1. Fillers
and Diluents
15.6.2.2.2. Binders
15.6.2.2.3. Suspension
and Viscosity Agents
15.6.2.2.4. Coatings
15.6.2.2.5. Flavoring
Agents
15.6.2.2.6. Disintegrants
15.6.2.2.7. Colorants
15.6.2.2.8. Lubricants
and Glidants
15.6.2.2.9. Preservatives
15.6.2.2.10. Sweeteners
15.6.2.2.11. Others
15.6.2.3. UAE Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Formulation
15.6.2.3.1. Oral
15.6.2.3.1.1. Solid
Dosage
15.6.2.3.1.2. Liquid
Dosage
15.6.2.3.2. Topical
15.6.2.3.3. Parenteral
15.6.2.3.4. Others
15.6.2.4. UAE Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
15.6.2.4.1. Direct
15.6.2.4.2. Indirect
15.6.3. Egypt
15.6.3.1. Egypt Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Origin
15.6.3.1.1. Organic
Chemical
15.6.3.1.2. Inorganic
Chemical
15.6.3.1.3. Others
15.6.3.2. Egypt Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Functionality
15.6.3.2.1. Fillers
and Diluents
15.6.3.2.2. Binders
15.6.3.2.3. Suspension
and Viscosity Agents
15.6.3.2.4. Coatings
15.6.3.2.5. Flavoring
Agents
15.6.3.2.6. Disintegrants
15.6.3.2.7. Colorants
15.6.3.2.8. Lubricants
and Glidants
15.6.3.2.9. Preservatives
15.6.3.2.10. Sweeteners
15.6.3.2.11. Others
15.6.3.3. Egypt Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Formulation
15.6.3.3.1. Oral
15.6.3.3.1.1. Solid
Dosage
15.6.3.3.1.2. Liquid
Dosage
15.6.3.3.2. Topical
15.6.3.3.3. Parenteral
15.6.3.3.4. Others
15.6.3.4. Egypt Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
15.6.3.4.1. Direct
15.6.3.4.2. Indirect
15.6.4. Kuwait
15.6.4.1. Kuwait Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Origin
15.6.4.1.1. Organic
Chemical
15.6.4.1.2. Inorganic
Chemical
15.6.4.1.3. Others
15.6.4.2. Kuwait Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Functionality
15.6.4.2.1. Fillers
and Diluents
15.6.4.2.2. Binders
15.6.4.2.3. Suspension
and Viscosity Agents
15.6.4.2.4. Coatings
15.6.4.2.5. Flavoring
Agents
15.6.4.2.6. Disintegrants
15.6.4.2.7. Colorants
15.6.4.2.8. Lubricants
and Glidants
15.6.4.2.9. Preservatives
15.6.4.2.10. Sweeteners
15.6.4.2.11. Others
15.6.4.3. Kuwait Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Formulation
15.6.4.3.1. Oral
15.6.4.3.1.1. Solid
Dosage
15.6.4.3.1.2. Liquid
Dosage
15.6.4.3.2. Topical
15.6.4.3.3. Parenteral
15.6.4.3.4. Others
15.6.4.4. Kuwait Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
15.6.4.4.1. Direct
15.6.4.4.2. Indirect
15.6.5. South
Africa
15.6.5.1. South Africa Pharmaceutical Excipient Market Revenue (US$ Mn)
and Forecasts, By Origin
15.6.5.1.1. Organic
Chemical
15.6.5.1.2. Inorganic
Chemical
15.6.5.1.3. Others
15.6.5.2. South Africa Pharmaceutical Excipient Market Revenue (US$ Mn)
and Forecasts, By Functionality
15.6.5.2.1. Fillers
and Diluents
15.6.5.2.2. Binders
15.6.5.2.3. Suspension
and Viscosity Agents
15.6.5.2.4. Coatings
15.6.5.2.5. Flavoring
Agents
15.6.5.2.6. Disintegrants
15.6.5.2.7. Colorants
15.6.5.2.8. Lubricants
and Glidants
15.6.5.2.9. Preservatives
15.6.5.2.10. Sweeteners
15.6.5.2.11. Others
15.6.5.3. South Africa Pharmaceutical Excipient Market Revenue (US$ Mn)
and Forecasts, By Formulation
15.6.5.3.1. Oral
15.6.5.3.1.1. Solid
Dosage
15.6.5.3.1.2. Liquid
Dosage
15.6.5.3.2. Topical
15.6.5.3.3. Parenteral
15.6.5.3.4. Others
15.6.5.4. South Africa Pharmaceutical Excipient Market Revenue (US$ Mn)
and Forecasts, By Distribution Channel
15.6.5.4.1. Direct
15.6.5.4.2. Indirect
15.6.6. Rest of
Middle East & Africa
15.6.6.1. Rest of Middle East & Africa Pharmaceutical Excipient
Market Revenue (US$ Mn) and Forecasts, By Origin
15.6.6.1.1. Organic
Chemical
15.6.6.1.2. Inorganic
Chemical
15.6.6.1.3. Others
15.6.6.2. Rest of Middle East & Africa Pharmaceutical Excipient
Market Revenue (US$ Mn) and Forecasts, By
Functionality
15.6.6.2.1. Fillers
and Diluents
15.6.6.2.2. Binders
15.6.6.2.3. Suspension
and Viscosity Agents
15.6.6.2.4. Coatings
15.6.6.2.5. Flavoring
Agents
15.6.6.2.6. Disintegrants
15.6.6.2.7. Colorants
15.6.6.2.8. Lubricants
and Glidants
15.6.6.2.9. Preservatives
15.6.6.2.10. Sweeteners
15.6.6.2.11. Others
15.6.6.3. Rest of Middle East & Africa Pharmaceutical Excipient
Market Revenue (US$ Mn) and Forecasts, By Formulation
15.6.6.3.1. Oral
15.6.6.3.1.1. Solid
Dosage
15.6.6.3.1.2. Liquid
Dosage
15.6.6.3.2. Topical
15.6.6.3.3. Parenteral
15.6.6.3.4. Others
15.6.6.4. Rest of Middle East & Africa Pharmaceutical Excipient Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
15.6.6.4.1. Direct
15.6.6.4.2. Indirect
15.7. Key
Segment for Channeling Investments
15.7.1. By
Country
15.7.2. By
Origin
15.7.3. By Functionality
15.7.4. By
Formulation
15.7.5. By
Distribution Channel
16. Latin America Pharmaceutical Excipient Market Analysis and Forecasts,
2022 - 2030
16.1. Overview
16.1.1. Latin
America Pharmaceutical Excipient Market Revenue (US$ Mn)
16.2. Latin
America Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts, By
Origin
16.2.1. Organic
Chemical
16.2.2. Inorganic
Chemical
16.2.3. Others
16.3. Latin
America Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts, By Functionality
16.3.1. Fillers
and Diluents
16.3.2. Binders
16.3.3. Suspension
and Viscosity Agents
16.3.4. Coatings
16.3.5. Flavoring
Agents
16.3.6. Disintegrants
16.3.7. Colorants
16.3.8. Lubricants
and Glidants
16.3.9. Preservatives
16.3.10. Sweeteners
16.3.11. Others
16.4. Latin
America Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts, By
Formulation
16.4.1. Oral
16.4.1.1. Solid Dosage
16.4.1.2. Liquid Dosage
16.4.2. Topical
16.4.3. Parenteral
16.4.4. Others
16.5. Latin
America Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
16.5.1. Direct
16.5.2. Indirect
16.6. Latin
America Pharmaceutical Excipient Market Revenue (US$ Mn) and Forecasts, By
Country
16.6.1. Brazil
16.6.1.1. Brazil Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Origin
16.6.1.1.1. Organic
Chemical
16.6.1.1.2. Inorganic
Chemical
16.6.1.1.3. Others
16.6.1.2. Brazil Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Functionality
16.6.1.2.1. Fillers
and Diluents
16.6.1.2.2. Binders
16.6.1.2.3. Suspension
and Viscosity Agents
16.6.1.2.4. Coatings
16.6.1.2.5. Flavoring
Agents
16.6.1.2.6. Disintegrants
16.6.1.2.7. Colorants
16.6.1.2.8. Lubricants
and Glidants
16.6.1.2.9. Preservatives
16.6.1.2.10. Sweeteners
16.6.1.2.11. Others
16.6.1.3. Brazil Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Formulation
16.6.1.3.1. Oral
16.6.1.3.1.1. Solid
Dosage
16.6.1.3.1.2. Liquid
Dosage
16.6.1.3.2. Topical
16.6.1.3.3. Parenteral
16.6.1.3.4. Others
16.6.1.4. Brazil Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
16.6.1.4.1. Direct
16.6.1.4.2. Indirect
16.6.2. Argentina
16.6.2.1. Argentina Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Origin
16.6.2.1.1. Organic
Chemical
16.6.2.1.2. Inorganic
Chemical
16.6.2.1.3. Others
16.6.2.2. Argentina Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Functionality
16.6.2.2.1. Fillers
and Diluents
16.6.2.2.2. Binders
16.6.2.2.3. Suspension
and Viscosity Agents
16.6.2.2.4. Coatings
16.6.2.2.5. Flavoring
Agents
16.6.2.2.6. Disintegrants
16.6.2.2.7. Colorants
16.6.2.2.8. Lubricants
and Glidants
16.6.2.2.9. Preservatives
16.6.2.2.10. Sweeteners
16.6.2.2.11. Others
16.6.2.3. Argentina Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Formulation
16.6.2.3.1. Oral
16.6.2.3.1.1. Solid
Dosage
16.6.2.3.1.2. Liquid
Dosage
16.6.2.3.2. Topical
16.6.2.3.3. Parenteral
16.6.2.3.4. Others
16.6.2.4. Argentina Pharmaceutical Excipient Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
16.6.2.4.1. Direct
16.6.2.4.2. Indirect
16.6.3. Rest of
Latin America
16.6.3.1. Rest of Latin America Pharmaceutical Excipient Market Revenue
(US$ Mn) and Forecasts, By Origin
16.6.3.1.1. Organic
Chemical
16.6.3.1.2. Inorganic
Chemical
16.6.3.1.3. Others
16.6.3.2. Rest of Latin America Pharmaceutical Excipient Market Revenue
(US$ Mn) and Forecasts, By Functionality
16.6.3.2.1. Fillers
and Diluents
16.6.3.2.2. Binders
16.6.3.2.3. Suspension
and Viscosity Agents
16.6.3.2.4. Coatings
16.6.3.2.5. Flavoring
Agents
16.6.3.2.6. Disintegrants
16.6.3.2.7. Colorants
16.6.3.2.8. Lubricants
and Glidants
16.6.3.2.9. Preservatives
16.6.3.2.10. Sweeteners
16.6.3.2.11. Others
16.6.3.3. Rest of Latin America Pharmaceutical Excipient Market Revenue
(US$ Mn) and Forecasts, By Formulation
16.6.3.3.1. Oral
16.6.3.3.1.1. Solid
Dosage
16.6.3.3.1.2. Liquid
Dosage
16.6.3.3.2. Topical
16.6.3.3.3. Parenteral
16.6.3.3.4. Others
16.6.3.4. Rest of Latin America Pharmaceutical Excipient Market Revenue
(US$ Mn) and Forecasts, By Distribution Channel
16.6.3.4.1. Direct
16.6.3.4.2. Indirect
16.7. Key
Segment for Channeling Investments
16.7.1. By
Country
16.7.2. By
Origin
16.7.3. By Functionality
16.7.4. By
Formulation
16.7.5. By
Distribution Channel
17. Competitive Benchmarking
17.1. Market
Share Analysis, 2020
17.2. Global
Presence and Growth Strategies
17.2.1. Mergers
and Acquisitions
17.2.2. Product
Launches
17.2.3. Investments
Trends
17.2.4. R&D
Initiatives
18. Player Profiles
18.1. ADM
18.1.1. Company
Details
18.1.2. Company
Overview
18.1.3. Product
Offerings
18.1.4. Key
Developments
18.1.5. Financial
Analysis
18.1.6. SWOT
Analysis
18.1.7. Business Strategies
18.2. Air Liquide
18.2.1. Company
Details
18.2.2. Company
Overview
18.2.3. Product
Offerings
18.2.4. Key
Developments
18.2.5. Financial
Analysis
18.2.6. SWOT
Analysis
18.2.7. Business
Strategies
18.3. Armor
Pharma
18.3.1. Company
Details
18.3.2. Company
Overview
18.3.3. Product
Offerings
18.3.4. Key
Developments
18.3.5. Financial
Analysis
18.3.6. SWOT
Analysis
18.3.7. Business
Strategies
18.4. Asahi
Kasei India Pvt. Ltd.
18.4.1. Company
Details
18.4.2. Company
Overview
18.4.3. Product
Offerings
18.4.4. Key
Developments
18.4.5. Financial
Analysis
18.4.6. SWOT
Analysis
18.4.7. Business Strategies
18.5. Ashland
18.5.1. Company
Details
18.5.2. Company
Overview
18.5.3. Product
Offerings
18.5.4. Key
Developments
18.5.5. Financial
Analysis
18.5.6. SWOT Analysis
18.5.7. Business
Strategies
18.6. BASF
Corporation
18.6.1. Company
Details
18.6.2. Company
Overview
18.6.3. Product
Offerings
18.6.4. Key
Developments
18.6.5. Financial
Analysis
18.6.6. SWOT
Analysis
18.6.7. Business
Strategies
18.7. BENEO
18.7.1. Company
Details
18.7.2. Company
Overview
18.7.3. Product
Offerings
18.7.4. Key
Developments
18.7.5. Financial
Analysis
18.7.6. SWOT
Analysis
18.7.7. Business
Strategies
18.8. Biogrund
GmbH
18.8.1. Company
Details
18.8.2. Company
Overview
18.8.3. Product
Offerings
18.8.4. Key
Developments
18.8.5. Financial
Analysis
18.8.6. SWOT
Analysis
18.8.7. Business
Strategies
18.9. Chemische
Fabrik Budenheim KG
18.9.1. Company
Details
18.9.2. Company
Overview
18.9.3. Product
Offerings
18.9.4. Key
Developments
18.9.5. Financial
Analysis
18.9.6. SWOT
Analysis
18.9.7. Business Strategies
18.10. Croda International Plc
18.10.1. Company
Details
18.10.2. Company
Overview
18.10.3. Product
Offerings
18.10.4. Key
Developments
18.10.5. Financial
Analysis
18.10.6. SWOT
Analysis
18.10.7. Business
Strategies
18.11. Daicel
Corporation
18.11.1. Company
Details
18.11.2. Company
Overview
18.11.3. Product
Offerings
18.11.4. Key
Developments
18.11.5. Financial
Analysis
18.11.6. SWOT
Analysis
18.11.7. Business Strategies
18.12. DuPont Pharma
18.12.1. Company
Details
18.12.2. Company
Overview
18.12.3. Product
Offerings
18.12.4. Key
Developments
18.12.5. Financial
Analysis
18.12.6. SWOT
Analysis
18.12.7. Business
Strategies
18.13. Evonik Industries
AG
18.13.1. Company
Details
18.13.2. Company
Overview
18.13.3. Product
Offerings
18.13.4. Key
Developments
18.13.5. Financial
Analysis
18.13.6. SWOT
Analysis
18.13.7. Business Strategies
18.14. FINAR
18.14.1. Company
Details
18.14.2. Company
Overview
18.14.3. Product
Offerings
18.14.4. Key
Developments
18.14.5. Financial
Analysis
18.14.6. SWOT
Analysis
18.14.7. Business
Strategies
18.15. Innophos
18.15.1. Company
Details
18.15.2. Company
Overview
18.15.3. Product
Offerings
18.15.4. Key
Developments
18.15.5. Financial
Analysis
18.15.6. SWOT
Analysis
18.15.7. Business
Strategies
18.16. Kerry
18.16.1. Company
Details
18.16.2. Company
Overview
18.16.3. Product
Offerings
18.16.4. Key
Developments
18.16.5. Financial
Analysis
18.16.6. SWOT
Analysis
18.16.7. Business
Strategies
18.17. Merck KGaA
18.17.1. Company
Details
18.17.2. Company
Overview
18.17.3. Product
Offerings
18.17.4. Key
Developments
18.17.5. Financial
Analysis
18.17.6. SWOT
Analysis
18.17.7. Business
Strategies
18.18. Roquette Frères
18.18.1. Company
Details
18.18.2. Company
Overview
18.18.3. Product
Offerings
18.18.4. Key
Developments
18.18.5. Financial
Analysis
18.18.6. SWOT
Analysis
18.18.7. Business Strategies
18.19. Wacker Chemie AG
18.19.1. Company
Details
18.19.2. Company
Overview
18.19.3. Product
Offerings
18.19.4. Key
Developments
18.19.5. Financial
Analysis
18.19.6. SWOT
Analysis
18.19.7. Business Strategies
18.20. Other
Market Participants
19. Key Findings
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.